Re: a clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma.
Doehn
Christian
C
D002294:Carcinoma, Squamous Cell / Q000401:mortality* / Q000601:surgery*; D006801:Humans; D007376:Interleukin-2 / Q000502:physiology; D008297:Male; D010412:Penile Neoplasms / Q000401:mortality* / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome
D007376:Interleukin-2